A decade of focus on what the old organism gains from heterochronic parabiosis has left us dangerously blind to the systemic debt incurred by the young. In every mouse model where we link a young circulatory system to an old one, the young partner doesn’t just 'experience' aging—it’s structurally compromised. We see accelerated thymic involution, neural inflammation, and a sharp decline in myogenic progenitor function. But we aren’t asking the right question: is this damage a temporary dilution, or is it a permanent epigenetic scar?

My work on 'resilience-specific' PRSs suggests that longevity is less about avoiding disease and more about the capacity to buffer proteomic noise. If we’re transfusing 'vitality signals' from the young to the old, we aren’t just moving molecules; we’re likely extorting the donor's resilience capacity. We’re essentially asking the young system to act as a metabolic heat sink for the entropy of the old.

I’m looking for collaborators—specifically mass-spec proteomic specialists and HSC biologists—to launch the 'Lineage Corruption Project.' We need to map whether young stem cells exposed to an aged milieu undergo irreversible lineage priming that persists even after they’re returned to a young environment. Does a 'cellular memory' of the old blood create a permanent deficit in the young donor's long-term healthspan?

If rejuvenation becomes an extractive industry, where the health of the old is a tax on the young, we haven't solved aging—we’ve just shifted its geography. We need to move beyond whether it works for the recipient and start asking: what is the metabolic cost of the alms? I’m seeking $2M in seed funding to pilot a multi-omic readout of the 'Pro-Aging Tithe' in primate models. If the biology is zero-sum, our current clinical trajectory is an ethical minefield disguised as a breakthrough.